URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit ...Middle East

PR Newswire - News
URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit

NEW YORK, June 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of UroGen Pharma Ltd. (NASDAQ: URGN) between July 27, 2023 and May 15, 2025, both dates inclusive (the "Class...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit )

    Also on site :



    Latest News